MUMBAI, INDIA, Feb 28, 2024 – (ACN Newswire) – In a considerable stride towards improving international health security and pandemic readiness, TechInvention Lifecare Pvt. Ltd. is happy to reveal the ground breaking of its Global Collaborative Centre for Medical Countermeasures (GCMC) with a financial investment of approx. USD 15 million. The centre is tactically situated near the approaching global airport in Navi Mumbai, India.
Model – Global Collaborative Centre for Medical Countermeasures (GCMC)
GCMC has actually been acknowledged for its international significance at the 2nd World Local Production Forum in The Hague on 6-8 November 2023, arranged by the WHO. The goal of GCMC is well lined up to WHO's call to action, CEPI's 100 days objective, India's National Biotechnology Development Strategy (2020-2025), and other worldwide essential efforts.
This center will serve the requirements of both public and personal companies, such as scholastic institutes, start-ups, MSMEs, and R&D companies, to offer a thorough environment, helping with the shift from R&D to GMP-scale production for pre-clinical/clinical batches with necessary regulative approvals.
GCMC is a distinct environmentally friendly centre to deal with important medical countermeasures– the whole cycle of vaccine advancement, from stress to provide, biotherapeutics and diagnostics for both human and veterinary sectors, while making sure sustainable production. This effort lines up with the One Health technique, highlighting the affiliation in between human, animal, and ecological health.
Mr. Syed S. Ahmed, Director and CEO of TechInvention, revealed, “The existing obstacles positioned in biologics equity occur from the variation in translational research study dissemination from the centres of quality to the local production ‘center and spoke' design setups. Our company believe that GCMC would be the required intervention, reinforcing the centers by offering ‘scaled-up', regulatory-approved, economical, and without IP violation biosolutions sourced from both native research study and centres of quality around the world”.
About TechInvention Lifecare Pvt. Ltd.: https://techinvention.biz/
TechInvention Lifecare Pvt. Ltd. differentiates itself as a special Indian biotech business, supporting the ‘One Health' principle by incorporating 3 critical interventions: diagnostics, vaccines, and biotherapeutics, dealing with both human and veterinary sectors. Its development is devoted to advancing worldwide health through unique options. With a concentrate on research study and advancement, the business is devoted to dealing with the health obstacles that might emerge in the future.
For more information, please contact:
Mr Sarang Pathak
+91 99606 16481
sarang@techinvention.biz
Subject: Press release summary
Source: TechInvention
Sectors: BioTech, Healthcare & & Pharm, MedTech
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights booked. A department of Asia Corporate News Network.
